Alpha Cognition (NASDAQ:ACOG) Trading Up 13.3% – Here’s What Happened
by Teresa Graham · The Cerbat GemAlpha Cognition Inc. (NASDAQ:ACOG – Get Free Report) rose 13.3% during trading on Friday . The stock traded as high as $5.20 and last traded at $5.10. Approximately 28,485 shares traded hands during trading, a decline of 58% from the average daily volume of 67,077 shares. The stock had previously closed at $4.50.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on ACOG shares. Wall Street Zen raised Alpha Cognition from a “sell” rating to a “hold” rating in a report on Saturday, November 15th. HC Wainwright reissued a “buy” rating and issued a $18.00 price objective on shares of Alpha Cognition in a research report on Friday, December 19th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $18.00.
Get Our Latest Report on Alpha Cognition
Alpha Cognition Stock Performance
The stock has a market capitalization of $110.87 million, a price-to-earnings ratio of -3.72 and a beta of 2.60. The business has a fifty day simple moving average of $5.82 and a 200 day simple moving average of $7.06.
Alpha Cognition (NASDAQ:ACOG – Get Free Report) last announced its earnings results on Thursday, November 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.13. The business had revenue of $2.84 million during the quarter, compared to the consensus estimate of $3.21 million.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Green Alpha Advisors LLC acquired a new stake in shares of Alpha Cognition in the fourth quarter valued at approximately $72,000. Geode Capital Management LLC bought a new position in Alpha Cognition during the 2nd quarter worth $112,000. Massar Capital Management LP bought a new position in Alpha Cognition during the 2nd quarter worth $116,000. Berkshire Asset Management LLC PA raised its holdings in Alpha Cognition by 50.7% in the 3rd quarter. Berkshire Asset Management LLC PA now owns 17,824 shares of the company’s stock valued at $116,000 after acquiring an additional 6,000 shares in the last quarter. Finally, Zullo Investment Group Inc. bought a new stake in shares of Alpha Cognition during the 3rd quarter valued at $127,000.
Alpha Cognition Company Profile
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.